You are viewing an archive version of the PSNC website taken on 18th April 2013. This site is not updated, and may be out of date or relate to old NHS structures.
For updated and current information, please visit our new website at
Skip Navigation
PSNC Home Page
Advanced Search

Pharmaceutical Services Negotiating Committee

Drug Tariff News

MHRA Class 2 Drug Alert: Tredaptive modified-release tablets

The MHRA have issued a class 2 drug alert for:

Merck Sharp & Dohme Ltd - Tredaptive modified-release tablets - Nicotinic acid and Laropiprant - EL (13)A/02

To view the alert please visit the MHRA website.

Posted 21 January 2013

< Back